Microsoft Outlook - Memo Style

1 downloads 0 Views 139KB Size Report
Nov 5, 2014 - Doris Stormyr Anderson Professor. Wake Forest Health Sciences. Winston Salem NC. Phone: 336-716-0231. From: [email protected] ...
Fei Xing, Ph.D. From: Sent: To: Subject:

Kounosuke Watabe, Ph.D. Wednesday, November 05, 2014 8:54 AM Fei Xing, Ph.D. FW: ONC-2014-01175R changes in Authorship

    From: Kounosuke Watabe, Ph.D. Sent: Wednesday, November 05, 2014 8:28 AM To: '[email protected]' Subject: RE: ONC-2014-01175R changes in Authorship

Dear Oncogene Editorial office:    I have collected emails from all authors regarding the authorship.  I combined all emails below.  Please let me know if  you need further documentation regarding this matter.  Thank you.  Ko Watabe    ******************************  Kounosuke Watabe, Ph.D.  Professor of Cancer Biology  Doris Stormyr Anderson Professor  Wake Forest Health Sciences  Winston Salem NC   Phone: 336‐716‐0231      ************************************************************************************************** ************************************************************************************************  From: Sambad Sharma Sent: Tuesday, November 04, 2014 6:09 PM To: Kounosuke Watabe, Ph.D. Subject: RE: authorship

  Dear Dr. Watabe,    I approve addition of Dr. Hui‐Wen Lo to this manuscript.    Thank You,  Sambad Sharma    ************************************************************************************************** *************************************************************************************************  From: Fei Xing, Ph.D. Sent: Tuesday, November 04, 2014 6:12 PM To: Kounosuke Watabe, Ph.D. Subject: RE: authorship

  Dr Watabe:  I approve this change.  1

  Fei Xing       ************************************************************************************************** ************************************************************************************************** *  From: yingyu zhang [mailto:[email protected]] Sent: Wednesday, November 05, 2014 8:16 AM To: Kounosuke Watabe, Ph.D. Subject: Re: Authorship

Dear Dr Watabe, i am agree with the addition of authorship. YingYu     ************************************************************************************************** ************************************************************************************************** *  From: Hui-Wen Lo, Ph.D. Sent: Tuesday, November 04, 2014 6:16 PM To: Kounosuke Watabe, Ph.D. Subject: RE: change of authorship

  Dear Dr. Watabe,    This is to acknowledge that you will  list me as a co‐author of the referred manuscript. I appreciate the opportunity to  work with you.     Sincerely,    Hui‐Wen  Hui‐Wen Lo, Ph.D.  Associate Professor of Cancer Biology  Department of Cancer Biology  Wake Forest University School of Medicine  4.4056 Hanes Building  Medical Center Blvd.  Winston‐Salem, NC 27157  Email: [email protected]  Phones: 336‐716‐0695 (O); 919‐760‐7330 (M)    ************************************************************************************************** ************************************************************************************************** ****  From: Yin-yuan Mo [mailto:[email protected]] Sent: Tuesday, November 04, 2014 6:24 PM To: Kounosuke Watabe, Ph.D. Subject: RE: authorship

  No problem. Thanks.  Yin  2

  ************************************************************************************************** ************************************************************************************************** *****  From: Kerui Wu Sent: Tuesday, November 04, 2014 6:31 PM To: Kounosuke Watabe, Ph.D. Subject: RE: authorship

  Dear Dr. Watabe,  I agree with the change that adds Dr. Hui‐Wen as a co‐author for the following manuscript‐ miR‐509 suppresses brain  metastasis of breast cancer cells by modulating RhoC and TNF a.  Regards,    Kerui Wu    ************************************************************************************************** ************************************************************************************************** *******  From: Yin Liu Sent: Tuesday, November 04, 2014 7:55 PM To: Kounosuke Watabe, Ph.D. Subject: RE: authorship

  Dr. Watabe, I approve the change of authorship. Yin

  ************************************************************************************************** ************************************************************************************************** *********  From: Luis A. Martinez [mailto:[email protected]] Sent: Tuesday, November 04, 2014 8:02 PM To: Kounosuke Watabe, Ph.D. Subject: RE: authorship

 

Dear Dr. Watabe, I approve the changes to the authorship list. best, Luis Dr. Luis Martinez Department of Biochemistry UMMC Cancer Institute The University of Mississippi Medical Center 2500 North State Street Jackson, MS 39216-4505 601-984-1521

************************************************************************************************** ************************************************************************************************** ******************  3

  From: Radhika Pochampally [mailto:[email protected]] Sent: Tuesday, November 04, 2014 8:48 PM To: Kounosuke Watabe, Ph.D. Subject: Re: authorship

  You have my approval :)  Radhika      ************************************************************************************************** ************************************************************************************************** *********************  From: "", "Ph.D."   Date: Tuesday, November 4, 2014 at 5:16 PM  To: Radhika Pochampally   Subject: authorship    Dear Dr. Radhika Pochampally:    

Thank you for your contribution to the manuscript listed below. We are submitting the revised manuscript soon. Because Dr. Hui-Wen Lo made contribution to this manuscript during the revision, we added her name as a co-author.   Oncogene requires consent from all authors to approve this change, and I appreciate it if you could send me your email response to approve the change at your earliest convenience. Thank you again. Ko Watabe       

In accordance to Nature Publishing Groups Authorship Policy we agree to change the authors of the manuscript as indicated below.   

NAME OF JOURNAL: Oncogene   

TITLE OF MANUSCRIPT: miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF a  MANUSCRIPT NUMBER: ONC-2014-01175R   

CORRESPONDING AUTHORS NAME: Kounosuke Watabe   

PREVIOUS AUTHOR NAMES:  Fei Xing, Sambad Sharma, Yin Liu, Yin-Yuan Mo, Kerui Wu, Ying-Yu Zhang, Radhika Pochampally, Luis A Martinez and Kounosuke Watabe   

UPDATED AUTHOR NAMES:  Fei Xing, Sambad Sharma, Yin Liu, Yin-Yuan Mo, Kerui Wu, Ying-Yu Zhang, Radhika Pochampally, Luis A Martinez, Hui-wen Lo and Kounosuke Watabe   

CHANGE TO AUTHOR LIST: Addition of Dr. Hui-Wen Lo        ******************************  4

Kounosuke Watabe, Ph.D.  Professor of Cancer Biology  Doris Stormyr Anderson Professor  Wake Forest Health Sciences  Winston Salem NC   Phone: 336‐716‐0231                 From: [email protected] [mailto:[email protected]] Sent: Tuesday, November 04, 2014 4:41 PM To: Kounosuke Watabe, Ph.D. Subject: ONC-2014-01175R changes in Authorship

Dear Dr Watabe, Thank you for sending your revised manuscript to Oncogene. It has come to our attention that your most recent author list differs from the one in your original submission. It is Nature Publishing Group's policy that any changes to the author list on a paper must be agreed by all of the authors. Please See www.nature.com/authors/editorial_policies/authorship.html for further details. Please request agreement from all authors including additions and deletions, these can be collected in the two following ways: 1) Approval Form Using the approval form available here; http://mtsnature.nature.com/letters/Author_List_Changes_Approval_form.docx, arrange for all authors on your paper to sign the statement confirming that they agree to the author list being changed, upload this as a single PDF to the journal's online tracking system as a 'related manuscript file' and resubmit your paper. 2) Email consent Email your co-authors with the change, and ask them to reply to your email confirming that they agree to these changes. Once you have collected these replies, please resubmit your manuscript and send all of the co-authors' email responses back to me in one combined file or email (not individually). Your paper has been placed back in the 'Author Approval Folder'. Once you have the authors' confirmation file, you can access your account at the following link and continue the submission : http://mts-onc.nature.com/cgibin/main.plex?el=A3BT5PsW4B2DQD6F5A9ftdzB5eRsiUz9TN11BwEeAZ ***Please remove this link if forwarding to your co-authors*** Thank you, Oncogene Editorial Office

5

ONC - This email has been sent through the NPG Manuscript Tracking System NY-610A-NPG&MTS Confidentiality Statement: This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com . Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html Privacy Policy | Update Profile

6